Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1NET 1Gastrointestinal 1Endocrine 1

Conditions

Prostatic Neoplasms 2Colorectal Neoplasms 2Otorhinolaryngologic Neoplasms 1Neuroendocrine Tumors 1Neoplasms 1Multiple Myeloma 1Lung Neoplasms 1Localized Head and Neck Carcinoma 1Gastrointestinal Neoplasms 1Disease 1Cardiovascular Diseases 1Breast Neoplasms 1Anxiety Disorders 1

Interventions

Oxaliplatin 6Fluorouracil 6Leucovorin 4Capecitabine 4Blood Specimen Collection 4Pafolacianine 3Cisplatin 3Cetuximab 3Bevacizumab 3pembrolizumab 2atezolizumab 2XELOX 2Surveys and Questionnaires 2Standard of Care 2Specimen Handling 2Paclitaxel 2Irinotecan 2IDRX-42 2Gemcitabine 2Folfox protocol 2Endoscopic Mucosal Resection 2Drug Therapy 2Docetaxel 2Carboplatin 2130-nm albumin-bound paclitaxel 2trastuzumab deruxtecan 1sodium thiosulfate 1sodium propionate 1sacituzumab govitecan 1s-formylglutathione hydrolase 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Gastrointestinal Neoplasms × Referral and Consultation × Clear all
NCT06908629 2025-08-26

Addressing Social Determinants of Health Among Metro Detroit Cancer Survivors

Barbara Ann Karmanos Cancer Institute

Phase NA Recruiting
120 enrolled
EndocrineGastrointestinalNETPlasma cell

Gastrointestinal Neoplasms, Multiple Myeloma, Neoplasms, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡